Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Prevention and Reduction of Falls: Testing and Evaluating Cutting Edge Haptic Technology

NCT: NCT07781397 · ENROLLING_BY_INVITATION

NCT IDNCT07781397
StatusENROLLING_BY_INVITATION
Start Date2025-06-16
Completion2026-12
SponsorSuperPatch Limited LLC (INDUSTRY)
First posted
Last updated

Brief Summary

This study evaluates whether a drug-free, non-invasive haptic patch (LIBERTY Patch) affects fall-risk classification and balance/mobility confidence in adults ages 55 to 85. Approximately 150 participants are assigned to wear either the active LIBERTY Patch or a visually identical sham patch daily for 7 days. Balance and mobility are assessed using the FallSkip wearable device and a Falls Efficacy Scale questionnaire at baseline and again after 7 days. Neither participants nor investigators know which patch is assigned during the study period, though this can be unblinded in an emergency.

Frequently Asked Questions

What is Prevention and Reduction of Falls: Testing and Evaluating Cutting Edge Haptic Technology?

Prevention and Reduction of Falls: Testing and Evaluating Cutting Edge Haptic Technology is a clinical trial registered under NCT07781397. Current status: ENROLLING_BY_INVITATION.

What is the status of NCT07781397?

The current status of NCT07781397 (Prevention and Reduction of Falls: Testing and Evaluating Cutting Edge Haptic Technology) is: ENROLLING_BY_INVITATION.

When did Prevention and Reduction of Falls: Testing and Evaluating Cutting Edge Haptic Technology start?

Prevention and Reduction of Falls: Testing and Evaluating Cutting Edge Haptic Technology started on 2025-06-16.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.